Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome

MeSH terms

• Aged
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Cyclophosphamide / administration & dosage
• Female
• Follow-Up Studies
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis*
• Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
• Male
• Middle Aged
• Time Factors
• Treatment Outcome
• Vidarabine / administration & dosage
• Vidarabine / analogs & derivatives